Malaysia Set to Produce Its First Human Vaccine in 2028 The Malaysian government's announcement that it will produce its first locally made human vaccine by 2028 has sparked hope for a more robust healthcare system.
The development of the 13 valent pneumococcal conjugate vaccine, or PCV13, marks a significant milestone in Malaysia's efforts to reduce reliance on imported vaccines and strengthen its health security.
Malaysia has long been heavily reliant on foreign suppliers for its vaccine needs, often at the mercy of international market fluctuations.